Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment

Journal of Infectious Diseases

Volumn 173, Issue 4, 1996, Pages 979-986

  Nabors, Gary S ^a,b   Farrell, Jay P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Connaught Laboratories ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; STIBOGLUCONATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG RESISTANCE; IMMUNE RESPONSE; IMMUNE STATUS; INFECTION RESISTANCE; INTRAMUSCULAR DRUG ADMINISTRATION; LEISHMANIASIS; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; RELAPSE; T LYMPHOCYTE;

EID: 0029933704     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.4.979     Document Type: Article

References (17)

1. Marsden PD, Jones TC. Clinical manifestations, diagnosis, and treatment of leishmaniasis. In: Chang KP, Bray RS, eds. Leishmaniasis. Cambridge, UK: Elsevier Science Publishers, 1985:183-98.
2. Grimaldi G Jr, Tesh RB. Leishmaniases of the new world: current concepts and implications for future research. Clin Microbiol Rev 1993;6:230-50.
3. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr 1966;34:255-73.
4. Carvalho EM, Teixeira RS, Johnson WD Jr. Cell mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 1981;33:498-502.
5. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD. Absence of gamma Interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 1985;76:2066-9.
6. Arnoldi J, Gerdes J, Flad HD. Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. Am J Pathol 1990;137:749-53.
7. Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG. Mitogen induced proliferation and cytokine production by lymphocytes from leprosy patients. Acta Lepr 1991;7:397-402.
8. Carvalho EM, Bacellar O, Brownell C, et al. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994;152:5949-56.
9. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988;168:1675-84.
10. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis. J Exp Med 1989;169:59-72.
11. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 1991;88:7011-5.
12. Rada E, Trujillo D, Castellanos P, Convit J. Gamma interferon production induced by antigens in patients with leprosy and American cutaneous leishmaniasis. Am J Trop Med Hyg 1987;37:520-4.
13. Convit J, Ulrich M, Fernandez CT, et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993;87:444-8.
14. Kemp M, Hey AS, Kurthals JAL, et al. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin Exp Immunol 1994;96:410-5.
15. Caceres-Dittmar G, Tapia FJ, Sanchez MA, et al. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 1993;91:500-5.
16. Melby P, Andrade-Narvaez FJ, Darnell BJ, Valencia-Pacheco G, Tryon V, Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect Immun 1994;62:837-42.
17. Zwingenberger K, Harms G, Pedrosa C, Omena S, Sandkamp B, Neifer S. Determinants of the immune response to visceral leishmaniasis: evidence for the predominance of endogenous interleukin-4 over interferon-γ production. Clin Immunol Pathol 1990;57:242-9.